why choose us

300×250 Ad Slot

Research Article: The 4th NextGen therapies of SJIA and MAS, part 4: it is time for IL-18 based trials in systemic juvenile idiopathic arthritis?

Date Published: 2024-01-05

Introduction:
A biomarker is a “defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions” according to the definition provided by FDA [1]. Biomarkers have always been a fundamental aspect of medical practice and drug development, but are not direct measures of how a person feels, functions, or survives. The Food and Drug Administration—National Institutes of Health (FDA-NIH) Biomarker Working…

Read more

300×250 Ad Slot